Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

(2010) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status: The Multiethnic Cohort Study

(2009) V. W. Setiawan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Molecular Subtypes of Breast Cancer Emerging in Young Women in Taiwan: Evidence for More Than Just Westernization as a Reason for the Disease in Asia

(2009) C.-H. Lin et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The 6q22.33 Locus and Breast Cancer Susceptibility

(2009) T. Kirchhoff et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer

(2009) Hiroko Yamashita et al.   CANCER SCIENCE

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

(2009) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042

(2009) Roger L. Milne et al.   JNCI-Journal of the National Cancer Institute

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

(2009) Gilles Thomas et al.   NATURE GENETICS

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1

(2009) Wei Zheng et al.   NATURE GENETICS

Breast cancer risk assessment for possible tailored screening for Japanese women

(2009) Yasuhiro Tamaki et al.   Breast Cancer

Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status

(2008) M. Garcia-Closas et al.   CLINICAL CANCER RESEARCH

Low phosphorylation of estrogen receptor   (ER ) serine 118 and high phosphorylation of ER  serine 167 improve survival in ER-positive breast cancer

(2008) H. Yamashita et al.   ENDOCRINE-RELATED CANCER

Possible Difference in Frequencies of Genetic Polymorphisms of Estrogen Receptor  , Estrogen Metabolism and P53 Genes Between Estrogen Receptor-positive and -negative Breast Cancers

(2008) M. Hamaguchi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

(2008) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY